US9174999, Table 1, Compound 5

ID: ALA3977689

Chembl Id: CHEMBL3977689

PubChem CID: 60135332

Max Phase: Preclinical

Molecular Formula: C13H23N7O4

Molecular Weight: 341.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)NC(=O)OC[C@@H]1NC(=N)N2CCC(O)(O)[C@@]23NC(=N)N[C@@H]13

Standard InChI:  InChI=1S/C13H23N7O4/c1-6(2)16-11(21)24-5-7-8-13(19-9(14)18-8)12(22,23)3-4-20(13)10(15)17-7/h6-8,22-23H,3-5H2,1-2H3,(H2,15,17)(H,16,21)(H3,14,18,19)/t7-,8-,13-/m0/s1

Standard InChI Key:  WZHKKWRCGDGTQN-UPFKWVMWSA-N

Associated Targets(Human)

SCN4A Tclin Sodium channel protein type IV alpha subunit (583 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Scn4a Sodium channel protein type IV alpha subunit (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 341.37Molecular Weight (Monoisotopic): 341.1812AlogP: -2.39#Rotatable Bonds: 3
Polar Surface Area: 165.82Molecular Species: BASEHBA: 6HBD: 8
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.76CX Basic pKa: 9.02CX LogP: -1.24CX LogD: -4.13
Aromatic Rings: Heavy Atoms: 24QED Weighted: 0.26Np Likeness Score: 1.48

References

1.  (2015)  Methods and compositions for studying, imaging, and treating pain, 

Source

Source(1):